Vol. 67, No. 3, 2000
Issue release date: May–June 2000
Respiration 2000;67:253–260
Clinical Investigations
Add to my selection

Geriatric Men at Altitude: Hypoxic Ventilatory Sensitivity and Blood Dopamine Changes

Serebrovskaya T.V.a · Karaban I.N.b · Kolesnikova E.E.a · Mishunina T.M.c · Swanson R.J.d · Beloshitsky P.V.a · Ilyin V.N.a · Krasuk A.N.a · Safronova O.S.a · Kuzminskaya L.A.c
aBogomoletz Institute of Physiology NASU, bInstitute of Gerontology AMSU, and cInstitute of Endocrinology AMSU, Kiev, Ukraine; dOld Dominion University, Norfolk, Va., USA
email Corresponding Author


 goto top of outline Key Words

  • High altitude
  • Hypoxic ventilatory response
  • Dopamine
  • Aging

 goto top of outline Abstract

Background: Short-term exposure to high-altitude hypoxia increases hypoxic ventilatory sensitivity (HVS) in healthy humans. Dopamine (DA) is the implicated neurotransmitter in carotid body (CB) chemoreceptor response, and the microenvironmental conditions in CB tissue are comparable to blood. Continuous DA infusion affected ventilation in animals and humans. Age-related oscillations in blood DA levels may influence peripheral chemoreflexes. Objective: Hypoxic ventilatory responses (HVR) relative to blood DA concentration and its precursor, dihydroxyphenylalanine (DOPA) was measured in young and elderly men during short-term altitude adaptation. Methods: Nine elderly climbers (group 1: 61 ± 1.4 years) and 7 young healthy subjects (group 2: 23 ± 2 years) were tested at sea level on day 0, on day 3 after passive transport to 2,200 m, and on day 14 after climbing to 4,200 and 5,642 m. Results: Sea level HVR in group 1 was 47% lower than in group 2, accompanied by higher blood DOPA (300%) and DA (37%) content. Initial DA and DOPA concentrations showed a negative correlation with initial HVR but a positive correlation with age. Passive transport to middle altitude (2,200 m) increased HVS, doubling HVR slopes in groups 1 and 2 and producing increased maximum expired minute ventilation during isocapnic rebreathing (29 and 28%, respectively). Day 3 2,200-meter blood DOPA content decreased by 22% in group 1 and increased by 300% in group 2. DA increased in both groups. Conclusion: The relationship between HVR and the reciprocal DA and DOPA values seen in both groups is associated with age, producing decreased DA receptor sensitivity and enhanced DA reuptake during adaptation to high altitude.

Copyright © 2000 S. Karger AG, Basel

goto top of outline introduction

Human life can be viewed as a time line spanning birth, infancy, childhood, adolescence, adulthood, senescence and death. Conforming to the laws of nature, the vigor of adult maturity is replaced by the increasing fragility of old age. Elderly individuals desire the same full and active life as younger adults in spite of biologically inescapable decreases in physiological processes and reserves. Humans past middle age find new ways peculiar to old age for accommodation, allowing them to ‘stay in the saddle’. Investigators must comprehend these adaptive mechanisms and help old people to enjoy implementing these mechanisms without detriment.

In recent years, many older men and women, especially former alpinists, have gone to high altitudes for recreation and sport, but little attention has been given to the effect of age on their tolerance to altitude. Honigman et al. [1] reported that 25% of the visitors from 16 to 87 years of age traveling to moderate elevations developed acute mountain sickness, but this phenomenon occurred mostly in the younger age group. Increased susceptibility to acute mountain sickness among younger persons was also noted by Hackett and Rennie [2]. Levine et al. [3] and Roach et al. [4] both noted that the elderly appear to acclimatize well to 2,500 m. These findings are surprising because some physiological components of gas exchange that maintain oxygenation, such as vital capacity and hypoxic ventilatory drive, decrease with age [1, 5, 6]. Levine et al. [3] noted that moderate altitude exposure in the elderly is associated with hypoxemia, sympathetic activation, and pulmonary hypertension resulting in a reduced exercise capacity. However, the hypoxic ventilatory response (HVR) is an essential defense mechanism against high-altitude hypoxia. There are data that the elderly have a reduced hypoxic ventilatory drive that may impair the normal adaptive response to altitude [7, 8, 9].

The mechanisms mediating changes in the ventilatory response during adaptation to hypoxia are not well understood, though there is evidence that dopamine (DA) is involved as a neurotransmitter in the carotid body (CB) chemoreceptor cells [10, 11, 12]. The catecholamines, DA and norepinephrine (NE), are synthesized and stored in CB chemosensory type I cells, and hypoxia mobilizes DA and NE in proportion to their stores in the tissues [13]. Studies have indicated age-related declines in the activity of several neurotransmitters in the central nervous system [14]. Additionally, DA has widespread effects in nonneural tissues as an endocrine and paracrine agent [15, 16]. Neurochemical data support the hypothesis that DA is an excitatory neurotransmitter in the CB [11, 17, 18], although DA, administered intravenously, results in ventilatory inhibition [19, 20].

The main sources of circulating DA and its precursor dihydroxyphenylalanine (DOPA) are sympathetic terminal endings, adrenal medulla chromaffin cells and paravertebral ganglia which are derived from common embryonic neuronal crest tissue together with chemoreceptor cells in the CB [21, 22]. The carotid bodies are rich in DA, but it is unlikely that they contribute materially to the plasma DA pool. On the contrary, blood DA concentration could reflexively influence the CB chemosensory function. The CBs are known as glomera because of their extensive capillary network. This unusually large flow is likely to establish a microenvironmental condition in the CB tissue comparable to blood alone [23]. Continuous infusion of DA, a common clinical treatment, affected ventilation in animals [24] and humans [25]. Thus, naturally occurring oscillations in blood DA levels may modulate peripheral chemoreflexes. Therefore we have measured a change in HVS relative to blood DA and DOPA concentration during short-term adaptation to altitude.


goto top of outline materials and methods

Two groups of old and young volunteers, sea level residents, participated in this study after having given informed consent. Group 1 consisted of 9 elderly climbers (5 men; 4 women) age 61.0 ± 1.47 years, weight 69 ± 2.9 kg; height 169 ± 1.9 cm. All subjects were in good physical condition. Less chronic disease was present in veteran climbers than is typical for elderly persons. Four climbers (44%) had moderate heart disorders (sinus arrhythmia, incomplete AV bundle block, and other factors indicative of coronary disease); 3 (33%) had hypertension; 3 (33%) had gastric, liver or intestinal disorders. No pulmonary disorder was registered in the old alpinist group. No one smoked. Most consumed one or more alcoholic beverages per day. Mean length of active climbing covered a 35-year span. However, no member of this group had climbed during the past 10 years due to the harsh political and economic situation in Ukraine.

Group 2 consisted of 7 young healthy climbers (3 men, 4 women) age 23.4 ± 2.0 years, weight 54.5 ± 3.1 kg; height 171 ± 1.9 cm. No one smoked or consumed alcohol in this group.

Both groups were tested at sea level, and twice at the Elbrus Medical Scientific Center in the Terskol settlement of the Caucasus mountains on the 3rd day and again on the 14th day after arrival at 2,200 m. During their stay at this altitude, all subjects participated in daily walking tours, initially at 3,000–3,500 m, then at 4,000–4,200 m. Four old alpinists and 2 young subjects successfully traversed the top of Mt. Elbrus (5,642 m) on the 13th day of sojourn at base-camp altitude. No headache, fatigue, shortness of breath or any other symptoms accompanying acute mountain sickness were observed in either young or veteran climbers after arriving at the final altitude. All alpinists maintained their prescribed activity and tolerated their sojourn at moderate altitude without incident. Furthermore, no serious disturbances were observed in the 4 elderly climbers while they climbed Mt. Elbrus.

All subjects were tested in the morning, on an empty stomach. Initially, venous blood was drawn from the median antecubital vein to measure NE, DA and DOPA content as described by Jakobowich and Richardson [26]. A fluorescence spectrophotometer (FMA-2A, Hitachi) was used for catecholamine measurements. Secondly, blood from the finger was drawn for measurement of hematological indices, i.e. hemoglobin (Hb) concentration, platelets (PLTs) and differential white blood cell (WBC) count. After 30 min of rest, the pulmonary function test was carried out in a sitting position using a pneumotachograph (Renaissance Spirometry System from Puritan-Bennett Company). Spirometric indices were derived automatically from the volume-time tracing produced by the microprocessor of the spirometer. All recordings were made by the same technician and the spirometric values were corrected for body temperature, atmospheric pressure and saturation.

After a 30-min rest, HVS was tested. Hypoxic ventilatory response (HVR) to isocapnic, progressively hypoxic rebreathing, in the sitting position was studied. Partial pressures of expiratory oxygen (PETO2) and carbon dioxide (PETCO2) were continuously monitored at the mouth with a medical mass spectrometer (MX62-02, USSR) which was calibrated before and after each test with standardized gases that had been assayed by the Scholander technique. Subjects breathed into a spirometer in which the O2 concentration fell with body utilization over time. Initial inspired gas composition (Fi) was 20.9% O2 and 79.1% N2. Rebreathing continued for 5–6 min until an FiO2 of 8–7% was reached. The period of severe hypoxia (FiO2 of 10–7%) lasted no more than 1.5 min. Subjects easily endured the severe hypoxia without any side effects. For the isocapnic hypoxic response measurements, PETCO2 was maintained at atmospheric pressure level by a special device which gradually diminished the volume (quantity) of CO2 absorbed as hyperventilation increased thereby preventing an unwarranted decrease (‘washing out’) in PCO2 level.

goto top of outline hvr calculation

Ventilatory responses were analyzed using the subject’s values for relative minute ventilation (&Vdot;E) with respect to PETO2. Curves were hyperbolic in shape. Usually, ventilatory and chemoreceptor responses to hypoxia are measured as a shape parameter A, which described the hyperbolic relationship between PETO2 and ventilation or carotid sinus nerve activity. This shape parameter has the advantage of describing the response over the entire range of PO2 values studied and produces a good description of raw data over a wide range of hypoxic responses from attenuated to broad [27]. An alternative method for estimation of HVRs was employed in this research; the piecewise linear approximation technique. This method, which we have described in previous studies [28, 29], allows comparison of ventilatory responses to weak (S1) and severe (S2) hypoxia, and to define the threshold (point of inflection) for maximum ventilatory rate increase (fracture point coordinates; FP) (fig. 1).


Fig. 1. Ventilatory responses to isocapnic progressive hypoxia at sea level and altitude in old (a) and young climbers (b). I = Sea level, II = 2,200 m altitude, day 3 after arrival; III = 2,200 m altitude, day 14 after arrival.

goto top of outline statistical tests

Statistics were performed using the analysis of variance (ANOVA) and Tukey’s test. Comparisons of young vs. old data were made using Wilcoxon’s unpaired test. All values were expressed as means ± SD. Correlations were identified by the least-squares method and expressed as linear regression slopes. Differences were considered significant when p < 0.05.


goto top of outline results

The initial sea level investigation revealed differences between young and old alpinists. Parameters of resting respiratory frequency (f) and tidal volume (VT) were not significantly different, but the mean value for specific lung ventilation (VE/kg) was 18% less in veterans (table 1a). We did no find marked differences in basic spirometric indices (table 1b). Significant differences in hypoxic ventilatory sensitivity were found (fig. 1). Though responses to a weak hypoxic stimulus (S1) did not differ between groups 1 and 2 (0.15 ± 0.01 and 0.15 ± 0.8 liters/min/mm Hg), there was a significant 47% mean HVR decrease in the severe hypoxia range (S2) in the older subjects (group 1: 0.31 ± 0.06 liters/min/mm Hg; Gr. 2: 0.59 ± 0.09 liters/min/mm Hg; p < 0.01). The diminution by 21% of maximal ventilation during the rebreathing test (VE, max) and the shift of the abscissa FP coordinate to lower levels of PETO2 also indicate a decrease in VHS in group 1. The low hypoxic sensitivity was accompanied by higher levels of blood DOPA and DA content (300 and 37%, respectively). A tendency toward increased levels of NE content (by 23%) was also found in old alpinists (fig. 2). Thus sea level DA and DOPA concentrations showed a strong positive correlation with age (r = 0.63; p < 0.05 and 0.76; p < 0.01, respectively) and a negative correlation with initial HVR (r = –0.61 and –0.65, respectively; p < 0.05) in groups 1 and 2 (fig. 3). At sea level, no significant differences were observed in hematological indices between old and young subjects (table 1c).


Fig. 2. Blood catecholamines at sea level and altitude in old (&karsi020;) and young (■) climbers. I = sea level, II = 2,200 m altitude, day 3 after arrival; III = 2,200 m altitude, day 14 after arrival. *p < 0.05, ** p < 0.01, statistically significant difference between group 1 and group 2; ∘ p < 0.05, ∘∘ p < 0.01, statistically significant difference between I and II; • p < 0.05, •• p < 0.01, statistically significant difference between I and III.


Fig. 3. Relation of baseline blood DOPA and DA content with age and hypoxic ventilatory response in group 1 (old) and group 2 (young) climbers. HVR(S2) = HVR, slope of sharp increase in ventilation; r = coefficient of correlation.


Table 1. Old men at altitude: respiratory and hematological indices

Passive transport to middle altitude (2,200 m) provoked considerable shifts in most investigated parameters in both old and young alpinists. Three days after arrival, lung ventilation at rest in group 2 increased by 22%, with only a trend for VE increase in group 1. During the whole stay at 2,200 m, VE/kg was significantly lower in old alpinists. Some differences were found in spirometric indices. FVC rose by 13% (490 ml) in young alpinists by the 14th day at 2,200 m while decreasing by 10% (440 ml) in veterans over the same period. A similar shift occurred in group 2 for forced expiratory volume at 15 (FEV1) and maximal lung ventilation (MLV), producing a rise of 41 and 32%, respectively, with no significant change in group 1 (table 1). Living at 2,200 m for 3 days increased HVS, doubling S2 for both group 1 (from 0.31 ± 0.06 to 0.73 ± 0.08 liters/min/mm Hg; p < 0.01) and group 2 (from 0.59 ± 0.09 to 1.17 ± 0.10 liters/min /mm Hg; p < 0.01), and producing an increase of VE,max during the isocapnic rebreathing test of 29 and 28%, respectively. After the 2 week adaptation, HVRs decreased slightly in both groups (fig. 1).

The most impressive differences between the two groups were observed in blood catecholamine content. On the 3rd day after arriving at 2,200 m, blood DOPA content increased by 300% in group 2 and decreased by 22% in group 1. DA increased in both groups, by 57% in group 2 and by 18% in group 1 making DA concentration equal in young and old groups at 2,200 m for 3 days. Two weeks of active adaptation produced a further rise in group 2 and fall in group 1 DOPA content. DA content decreased slightly in both groups at 2,200 m for 14 days. When compared to sea level values, DA concentration finished higher by 28% in group 2, with no significant difference in group 1. On the 3rd day at 2,200 m, NE content increased by 200% in young subjects and by 56% in old subjects. By the 14th day, this parameter slightly decreased in both groups. When compared to sea level values, the final concentration was 63% higher in group 2 and 48% higher in group 1 (fig. 2). Hematological factors of Hb, PLTs, WBCs, and band leukocyte count all increased while eosinophils decreased in both groups. There was no significant difference between group 1 and group 2 in hematological parameters at altitude, except for enhanced PLTs in the older climbers (table 1c).


goto top of outline discussion

Healthy sexagenarian alpinists in this investigation climbed high altitudes successfully. The effects of high altitudes on climbers included the observation of a reciprocal relationship between changes in HVS and blood DOPA content in old age and youth. Initially, veterans did not differ from young subjects in spirometric and hematological indices, but were characterized by lower specific lung ventilation at rest and lower HVS accompanied by higher venous blood DOPA and DA content. These differences were assumed to be the result of aging. Adaptation to a 2,200-meter altitude provoked augmentation in HVRs both in old and young climbers, but this increase was accompanied by a great increase in DA and NE blood content in group 2 while group 1 demonstrated only a slight increase. The most striking differences were found in DOPA concentration shifts: swift augmentation in young climbers just after arriving at altitude with further increase during the 2 week period of adaptation, and significant decrease in old subjects with a further reduction over time. As a result, DA content remained higher in group 1 compared to group 2, but there was an inversion in DOPA concentration between the two groups in proceeding from sea level to 2,200 m. Spirometric differences at altitude for group 2 included a gradual rise in forced vital capacity (FVC), FEV1 and MLV but no significant spirometric changes occurred in group 1. There were no hematological differences between group 1 and group 2 at sea level or altitude except for an augmentation of PLT count in group 1.

The fact that short-term exposure to high-altitude hypoxia results in increases in HVS in humans and animals is well established and summarized in many reviews [18, 30, 31]. The mechanisms responsible for this increase have remained unclear, but could involve events happening on both central and peripheral levels. Data suggest that carotid chemoreceptor activity plays a key role in ventilatory acclimatization to hypoxia [10, 12, 32]. Released acutely from type I glomus cells in the CB by hypoxic stimuli, DA has been postulated as the excitatory transmitter for sinus nerve endings [11, 17, 33, 34]. However, intravenous or intra-arterial infusion of DA induced transient inhibition of both sinus nerve action potential conduction and lung ventilation [24, 35, 36, 37], supporting the concept of an inhibitory role for DA in the regulation of respiration. Previous studies in normal humans have shown that aging is associated with a reduced ventilatory response to hypoxia [7, 8, 9, 38]. Although our earlier investigation did not find a decrease in HVRs in 5 older male subjects [39], the present study recorded a significant decrease in HVS with age at both sea level and 2,200 m altitude. The fact that this depression was accompanied by an increased DA and DOPA blood content at sea level should corroborate the theory of an inhibitory action for DA on ventilation. However, we found no significant correlation between individual DA and DOPA content changes during high-altitude adaptation when compared to changes in HVRs in groups 1 and 2. DA released by CB type I cells and the high DA concentration in the synaptic cleft probably does not significantly influence DA blood concentration [40]. Furthermore, exogenously administered DA flowing to the CB could provoke DA autoreceptor-mediated inhibition of endogenous DA release which would produce the decreased HVR in subjects with high blood DA concentration by the principle of autoregulation. Venous blood DA probably does not reflect events happening at the synaptic cleft between type I cells (releasing dopamine) and postsynaptic receptors on the afferent nerve terminals.

In the present study, we observed a higher level of blood DA and a trend to higher NE content in the older subjects. Age-related increases in plasma catecholamine concentration are well documented in healthy humans [41, 42, 43]. This phenomenon is explained in part by the decrease in neuronal reuptake [44, 45, 46]. As Esler et al. [47] suggest, reduced NE reuptake increases the overflow of the neurotransmitter to plasma from the aging heart during stimulation of the cardiac sympathetic outflow. Some authors have suggested that hypoxia activates the sympathoadrenal system and enhances the blood catecholamine content in young persons [48]. This augmentation could lead to smooth muscle relaxation in the respiratory tract, and thus explain the increase in FEV1 and VE,max at altitude in young persons. Our data, however, showed no significant differences in NE blood content between old and young subjects at 2,200 m. Ng et al. [46] also reported that plasma NE responses to stress did not differ in old when compared with young subjects.

As Gonzalez-Guerrero et al. [17] reported, isolated CBs cultured under hypoxia for 8 days in vitro, synthesized DA twice as fast as in control animals. Moreover, the content of tyrosine hydroxylase (TH), was gradually increased in rat CBs after adaptation to hypoxia, and the turnover of DA and NE in in vitro CB culture was increased by 15- and 5-fold, respectively [49]. The activity of the plasma enzyme dopamine-β-hydroxylase has been reported to be increased due to exposure to altitude hypoxia [50]. DOPA level in the plasma is maintained by spontaneous output from chromaffin cells of the adrenal medulla and from the sympathetic nervous system, and is approximately proportional to the rates of NE turnover [22, 51]. The limiting factor of DOPA synthesis is TH. Aging is associated with decreased TH activity and therefore we would expect a decrease in DOPA content with age. However, we registered a 3-fold increase in this amine in the blood of the older subjects when challenged hypoxically at sea level, but a 22% decrease at 2,200 m. These sea level data are confirmed by our observations on 8 older nonalpinist sea level residents [52]. Furthermore, the urinary excretion of DOPA in group 1 exceeded that in young subjects. TH is an O2-dependent enzyme [53]. TH gene expression starts within hours after hypoxia [23] and can be provoked by increased intracellular Ca2+ and/or increased firing rate of catecholaminergic neurons [22, 54]. In rats, adrenal gland DOPA content increased 2.3 times after a 7-day exposure to hypoxia [53]. The above-mentioned mechanism could explain the enhancement of blood DOPA and subsequent DA concentration in young subjects during their stay at 2,200 m. Activation of the sympathoadrenal system can also promote an increase in DOPA output into blood [22]. The decrease in blood DOPA content in older subjects at 2,200 m remains unclear. We speculate that the relationship between HVR and the reciprocal DA/DOPA values seen in groups 1 and 2 is associated with age, producing both decreased DA receptor sensitivity and enhanced DA reuptake during adaptation to high altitude.


goto top of outline summary

This investigation shows that old alpinists can successfully climb up to high altitudes such as 5,642 m in spite of measurably decreased HVS. At sea level, this decreased sensitivity was associated with high venous DOPA and DA contents. There were quantifiably significant differences in sea level versus 2,200-meter catecholamine values in both group 1 and group 2 subjects. DOPA values were markedly different in group 1 and group 2 at sea level and after 14 days at 2,200 m, but there was an inversion of these two measurements. Group 1 had higher values than group 2 at sea level and lower values than group 2 at the 14-day 2,200-meter sampling. This difference is thought to be due to aging-related phenomena.


goto top of outline acknowledgments

The authors thank Prof. John T. Reeves (Denver, Colo., USA) for helpful comments on the manuscript and Dr. Toshio Kobayashi (Matsumoto, Japan) for financial support and equipment.

 goto top of outline References
  1. Honigman B, Theis MK, Koziol-McLain J, Roach R, Yip R, Houston C, Moore LG: Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med 1993;118:587–592.
  2. Hackett PH, Rennie D: The incidence, importance and prophylaxis of acute mountain sickness. Lancet 1976;ii:1149–1155.
  3. Levine BD, Zuckerman JH, deFilippi CR: Effect of high-altitude exposure in the elderly. The Tenth Mountain Division study. Circulation 1997;96:1224–1232.
  4. Roach RC, Houston CS, Honigman B, et al: How well do older persons tolerate moderate altitude? West J Med 1995;162:32–36.
  5. Dill DB, Stanley D, Miller H, Miller J: Vital capacity, exercise performance, and blood gases at altitude as related to age. J Appl Physiol 1980;48:6–9.

    External Resources

  6. Davies CT: The oxygen transporting system in relation to age. Clin Sci 1972;42:1–13.

    External Resources

  7. Peterson DD, Pack AI, Silage DA, Fishman AP: Effects of aging on ventilatory and occlusion pressure responses to hypoxia and hypercapnia. Am Rev Respir Dis 1981;124:387–391.
  8. Chapman KR, Cherniak NS: Aging effects on the interaction of hypercapnia and hypoxia as ventilatory stimuli. J Gerontol 1987;42:202–209.

    External Resources

  9. Monge CC: Medical research in the Andes. Ann Sports Med 1988;4:245–254.
  10. Forster HV, Bisgard GE, Klein JP: Effect of peripheral chemoreceptor denervation on acclimatization of goats during hypoxia. J Appl Physiol 1981;50:392–398.

    External Resources

  11. Fidone S, Gonzalez C, Yoshizaki R: Effects of low oxygen on the release of dopamine from the rabbit carotid body in vitro. J Physiol (Lond) 1982;333:93–110.

    External Resources

  12. Engwall MJA, Bisgard GE: Ventilatory responses to chemoreceptor stimulation after hypoxic acclimatization in awake goats. J Appl Physiol 1990;69:1236–1243.
  13. Chen J, Gomez-Nino A, Gonzalez C, Dinger B, Fidone S: Stimulus-specific mobilization of dopamine and norepinephrine stores in cat carotid body. J Auton Nerv Syst 1997;67:109–113.

    External Resources

  14. Fanning P, O’Boyle KM: Effect of age on rat striatal G protein activation by dopamine and serotonin (poster). J Physiol (Lond) 1997;171P.
  15. Bairam A, Hannhart B, Chone C, Marchal F: Effect of dopamine on carotid chemoreceptor activity in newborn kittens. Biol Neonate 1994;65:140–144.

    External Resources

  16. Cheung Po-Yin, Barrington KJ: Renal dopamine receptors: Mechanisms of action and developmental aspects. Cardiovasc Res 1996;31:2–6.
  17. Gonzalez-Guerrero PR, Rigual R, Gonzalez C: Effects of chronic hypoxia on opioid peptide and catecholamine levels and on the release of dopamine in the rabbit carotid body. J Neurochem 1993;60:1769–1776.

    External Resources

  18. Bisgard GE, Janssen PL: Mechanisms of ventilatory acclimatization to hypoxia in vivo; in Houston CS, Coates G (eds): Women at Altitude. Burlington, Queen City Printers, 1997, pp 142–146.
  19. Okajima Y, Nisni K: Analysis of inhibitory and excitatory actions of dopamine on chemoreceptor discharges of carotid body of cat in vivo. Jpn J Physiol 1981;31:695–704.
  20. Wypych B, Szereda-Przestaszewska M: Depression of ventilation by dopamine in cats: Effects of bilateral cervical sympathetic and vagal trunk section. Exp Physiol 1995;80:255–263.
  21. Smitten NA: Cytological and ultrastructural pattern of the secretory activity of adrenomedullar cells. Arch Anat Microsc Morph Exp 1965;54:45–162.
  22. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G: Overflow of catecholamine neurotransmitter to the circulation: Source, fate, and functions. Physiol Rev 1990;70:963–985.
  23. Acker H, Xue D: Mechanisms of O2 sensing in the carotid body in comparison with other O2-sensing cells. NIPS 1995;10:211–216.
  24. Ide T, Shirahata M, Chou CL, Fitzgerald RS: Effects of a continuous infusion of dopamine on the ventilatory and carotid body responses to hypoxia in cats. Clin Exp Pharmacol Physiol 1995;22:658–664.

    External Resources

  25. Welsh MJ, Heistad DD, Abboud FM: Depression of ventilation by dopamine in man. J Clin Invest 1978;61:708–713.

    External Resources

  26. Jakobowich PM, Richardson GS: Method for the rapid determination of norepinephrine, dopamine and serotonine in the same brain region. Pharmacol Biochem Behav 1979;8:515–519.

    External Resources

  27. Weil JV, Burne-Quinn E, Sodal IE, Klein JS, McCullough RE, Filley GF: Augmentation of chemosensitivity during mild exercise in normal man. J Appl Physiol 1972;33:813–819.

    External Resources

  28. Serebrovskaya TV, Vergulis TG: The method for estimation of the human hypoxic and hypercapnic sensitivity; in Problems of Respiratory and Circulatory Regulation. Kujbyshev, 1985, pp 56–62.
  29. Serebrovskaya TV, Karaban IN, Kolesnikova EE, Mishunina TM, Kuzminskaya LA, Serebrovsky AN, Swanson RJ: Human hypoxic ventilatory response with blood dopamine content under intermittent hypoxic training. Can J Physiol Pharmacol 1999;77:967–973.
  30. Dempsey JA, Forster HV: Mediation of ventilatory adaptation. Physiol Rev 1982;62:262–346.
  31. Weil JV: Ventilatory control at high altitude; in Geiger SR, Cherniack NS, Widdicombe JG, Fishman AP (eds): Handbook of Physiology. The Respiratory System II. Bethesda, American Physiological Society, 1986, pp 703–729.
  32. Lahiri S, Edelman NH, Cherniack NS, Fishman AP: Role of carotid chemoreflex in respiratory acclimatization to hypoxemia in goat and sheep. Respir Physiol 1981;46:367–382.
  33. Shaw K, Montagne V, Pallot DJ: Biochemical studies on release of catecholamines from rat carotid body in vitro. Biochim Biophys Acta 1989;1013:42–46.

    External Resources

  34. Zapata P, Larrain C: The role of dopamine in arterial chemoreception: A controversial issue. 33rd Int Congr Physiol Sci, St Petersburg 1997, P030.27.
  35. Bisgard GE, Forster HV, Klein JP, Manohar M, Bullard VA: Depression of ventilation by dopamine in goats. Effects of carotid body excision. Respir Physiol 1980;41:379–392.
  36. Olson LG, Hensley MJ, Saunders NA: Ventilatory responsiveness to hypercapnic hypoxia during dopmaine infusion in humans. Am Rev Respir Dis 1982;126:783–787.
  37. Ryan ML, Hedrick MS, Pizarro J, Bisgard GE: Carotid body noradrenergic sensitivity in ventilatory acclimatization to hypoxia. Respir Physiol 1993;92:77–90.
  38. Strohl KP, Beal CM: Ventilatory response to experimental hypoxia in adult male and female natives of the Tibetan and Andean plateaus; in Houston CS (ed): Hypoxia. Women at Altitude. Burlington, Queen City Printers, 1997, pp 154–163.
  39. Serebrovskaya TV, Karaban IN, Mankovskaya IN, Bernardi L, Passino C, Appenzeller O: Hypoxic ventilatory responses and gas exchange in patients with Parkinson’s disease. Respiration 1998;65:28–33.
  40. Gonzalez C, Almaraz L, Obeso A, Rigual R: Carotid body chemoreceptors: From natural stimuli to sensory discharges. Physiol Rev 1994;74:829–898.
  41. Goldstein DC, Lake C, Chernov B, Ziegler MG, Coleman MD, Taylor AA, Mitchell JR, Kopin IJ, Keiser HR: Age-dependence of hypertensive-normotensive differences in plasma norepinephrine. Hypertension 1983;5:100–104.

    External Resources

  42. Morrow LA, Linares OA, Hill TJ, Sanfield JA, Supiano MA, Rosen SG, Halter JB: Age differences in the plasma clearance mechanisms for epinephrine and norepinephrine in humans. J Clin Endocrinol Metab 1987;65:508–511.
  43. Jackson A, Nurse D: Dopaminergic properties of cultured rat carotid body chemoreceptors grown in normoxic and hypoxic environments. J Neurochem 1997;69:645–654.
  44. Esler MD, Lambert G, Jennings G: The influence of aging on catecholamine metabolism; in Amery A, Staessen J (eds): Handbook of Hypertension: Hypertension in the Eldery. New York, Elsevier, 1989, vol 12, pp 85–98.
  45. Holdtke RD, Cilmi KM: Effects of aging on catecholamine metabolism. J Clin Endocrinol Metab 1985;60:479–484.
  46. Ng AV, Callister R, Johnson DG, Seals DG: Sympathetic neural reactivity to stress does not increase with age in healthy humans. Am J Physiol 1994;267:H344–H353.

    External Resources

  47. Esler MD, Thompson JM, Kaye DM, Turner AG, Jennings GL, Cox HS, Lambert GW, Seals DR: Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors. Circulation 1995;91:351–358.
  48. Asano K, Mazzeo RS, McCullough BC, Wolpel EE, Reeves JT: Relation of sympathetic activation to ventilation in man at 4300 m altitude. Aviat Space Environ Med 1997;68:104–110.
  49. Schmitt P, Garcia C, Soulier V, Pujol JF, Pequignot JM: Influence of long-term hypoxia on tyrosine hydroxylase in the rat carotid body and adrenal gland. J Auton Nerv Syst 1992;40:13–19.
  50. Koudelova J, Mourek J: Influence of age, sex and hypoxia on plasma dopamine-beta-hydroxylase activity in the rat. Physiol Bohemoslov 1990;39:409–416.
  51. Eisenhofer G, Smolich JL, Esler MD: Increased cardiac production of dihydroxyphenylanine (Dopa) during sympathetic stimulation in anesthetized dogs. Neurochem Int 1992;21:37–44.
  52. Serebrovskaya TV, Karaban IN, Kolesnikova EE, Mishunina TM, Mankovskaya IN: Old men and patients with Parkinson’s disease under intermittent hypoxic training. 2. Blood dopamine and DOPA content. 11th International Hypoxia Symposium, Jasper, 1999, p 148.
  53. Dalmaz Y, Pequignot JM, Cottet-Emard JM, Peyrin L: Adrenal response to long-term hypoxia is still increased after carotid body degeneration in rat. J Appl Physiol 1994;76:1049–1054.
  54. Millhorn DE, Raymond R, Conferti L, Zhu W, Beitner-Johnson D, Filisko T, Genter MB, Kobayashi S, Peng M: Regulation of gene expression for tyrosine hydroxylase in oxygen sensitive cells by hypoxia. Kidney Int 1997;51:527–535.

    External Resources

 goto top of outline Author Contacts

Tatiana V. Serebrovskaya, PhD
Bogomoletz Institute of Physiology
Ukrainian Academy of Sciences
4 Bogomoletz Street, 252024 Kiev (Ukraine)
Tel. +380 44 256 2492, Fax +380 44 293 3431, E-Mail sereb@mail.kar.net

 goto top of outline Article Information

Received: Received: August 4, 1998
Accepted after revision: September 5, 1999
Number of Print Pages : 8
Number of Figures : 3, Number of Tables : 1, Number of References : 54

 goto top of outline Publication Details

Respiration (International Review of Thoracic Diseases)
Founded 1944 as ‘Schweizerische Zeitschrift für Tuberkulose und Pneumonologie’ by E. Bachmann, M. Gilbert, F. Häberlin, W. Löffler, P. Steiner and E. Uehlinger, continued 1962–1967 as ‘Medicina Thoracalis’

Vol. 67, No. 3, Year 2000 (Cover Date: May-June 2000)

Journal Editor: C.T. Bolliger, Cape Town
ISSN: 0025–7931 (print), 1423–0356 (Online)

For additional information: http://www.karger.com/journals/res

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.